Skip to main content
Tech.euFundingExplorerBeta

Healthtech funding in H2 2013

European Healthtech startup funding raised during H2 2013.

In H2 2013, 60 European Healthtech companies closed 62 funding rounds and raised €328M in equity funding (excluding debt and grants), up 11.4% versus H2 2012. Switzerland led by capital raised, and Bpifrance was the most active investor. Data as of 6 Nov 2026.

Equity funding
€328M
+11.4% vs H2 2012 · excl. debt & grants
Funding rounds
62
+63.2% vs H2 2012
Companies
60
Top country
Switzerland
Rank among sectors
#3
11.3% of sector funding
Top-10 round share
73.9%
of disclosed capital

Funding by month

€ raised vs rounds, by month
Healthtech — funding by month, H2 2013 — interactive chart.
Data table
FundingRounds
Jul€31M9
Aug€32M9
Sep€78M14
Oct€100M13
Nov€77M13
Dec€10M4

Top countries

by € raised
Healthtech — top countries by capital, H2 2013 — interactive chart.
Data table
Healthtech — top countries by capital, H2 2013
Switzerland€106M
France€80M
UK€39M
Germany€36M
Netherlands€31M
Israel€13M
Denmark€8.2M
Belgium€6.5M

Stage mix

by € raised
Healthtech — stage mix, H2 2013 — interactive chart.
Data table
Healthtech — stage mix, H2 2013
Series B€113M
Growth/Late€67M
Other€66M
Series A€36M
Series D+€30M
Seed€8.3M
Early VC€4.3M
Series C€3.0M
Grant€185k

Top deals

largest disclosed rounds in H2 2013
CompanyStageDateAmount
MerusSeries BOct 2013€31M
EvotecGrowth/LateSep 2013€30M
BiocartisSeries D+Nov 2013€30M
ADC TherapeuticsGrowth/LateOct 2013€30M
ObsEvaSeries AAug 2013€26M
MISSION TherapeuticsSeries BNov 2013€24M
WiThingsSeries BJul 2013€23M
CeQurSeries BSep 2013€20M
Pixium VisionOtherNov 2013€15M
THERAVECTYSOtherOct 2013€15M
Morria BiopharmaceuticalsOtherOct 2013€11M
Gecko BiomedicalOtherDec 2013€9.9M
SimpleeSeries BSep 2013€7.6M
EgaletGrowth/LateSep 2013€7.6M
Epigenomics AGOtherAug 2013€5.0M

Top investors

most active in H2 2013, by deal count